Abbott India Limited
ABBOTINDIA
Rang in aandelen
#3022
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Aandeelprijs
$284.73
Marktkapitalisatie
$6.05B
Verandering (1 dag)
-0.41%
Verandering (1 jaar)
-17.16%
Land
IN
Handel Abbott India Limited (ABBOTINDIA)
Categorie
Healthcare
Winst voor Abbott India Limited (ABBOTINDIA)
Winst in Jun 2026 TTM: $238.19M
Volgens de meest recente financiële verslagen van Abbott India Limited bedraagt de huidige winst van het bedrijf $238.19M. In 2024 behaalde het bedrijf een winst van $194.01M, een stijging ten opzichte van de winst van 2023, die $155.00M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Abbott India Limited van 2004 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $238.19M | 7.96% |
| 2025 | $220.63M | 13.72% |
| 2024 | $194.01M | 25.17% |
| 2023 | $155.00M | 8.97% |
| 2022 | $142.24M | 12.45% |
| 2021 | $126.49M | 18.71% |
| 2020 | $106.55M | 5.87% |
| 2019 | $100.64M | 5.44% |
| 2018 | $95.45M | 41.81% |
| 2017 | $67.31M | 12.04% |
| 2016 | $60.08M | 8.86% |
| 2015 | $55.19M | 39.00% |
| 2014 | $39.70M | 1.44% |
| 2012 | $39.14M | 15.33% |
| 2011 | $33.94M | 61.11% |
| 2010 | $21.06M | -16.67% |
| 2009 | $25.28M | 33.27% |
| 2008 | $18.97M | -26.36% |
| 2007 | $25.76M | 31.50% |
| 2006 | $19.59M | 3.19% |
| 2005 | $18.98M | -38.51% |
| 2004 | $30.87M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $33.60B | 14,004.37% |
US
|
|
| $17.74B | 7,346.49% |
US
|
|
| $8.70B | 3,552.08% |
US
|
|
| $5.95B | 2,397.14% |
US
|
|
| $21.39B | 8,879.40% |
CH
|
